Archive: Feb 2011

-- Synthetic biologists are a new breed of researchers: part-scientist, part-engineer. Building on the work of more traditional biologists, synthetic biologists try to use what we know about biology to engineer new functions into living things, such as…

-- Scientists and prostate cancer patients alike cheered when the FDA approved Provenge, the first therapeutic vaccine for prostate cancer, in April 2010. A few months later, a second group of researchers published a clinical study that suggested the…